Table 3—

Association between SDB and IGM in all participants and according to weight status

IGMEntire analytic sample (n = 2,588)
Nonoverweight (n = 679)*
Overweight/obese (n = 1,909)
Unadjusted odds ratio (95% CI)Adjusted odds ratio (95% CI)Unadjusted odds ratio (95% CI)Adjusted odds ratio (95% CI)Unadjusted odds ratio (95% CI)Adjusted odds ratio (95% CI)
IFG2.0 (1.7–2.4)1.3 (1.1–1.6)§1.5 (1–2.3)1.6 (1–2.5)1.8 (1.5–2.2)1.3 (1–1.6)
IGT1.3 (1.1–1.6)1.2 (1–1.4)1.5 (1–2.1)1.4 (0.9–2.1)1.2 (1–1.5)1.1 (0.9–1.4)
IFG plus IGT2.0 (1.6–2.5)1.4 (1.1–1.8)§1.8 (0.9–3.4)1.9 (1–3.7)1.7 (1.3–2.3)1.3 (1–1.8)
Occult diabetes detected as FPG ≥126 mg/dl2.4 (1.6–3.6)1.7 (1.1–2.7)2.3 (0.8–6.6)2.5 (0.8–8.0)2.1 (1.4–3.3)§1.6 (1–2.6)
Occult diabetes detected as 2-h OGTT ≥200 mg/dl1.8 (1.3–2.3)1.5 (1.2–2.0)§2.0 (1.1–3.6)1.7 (0.9–3.2)1.6 (1.2–2.1)§1.5 (1.1–2.0)
  • *

    * BMI <25 kg/m2.

  • BMI ≥25 kg/m2.

  • Adjusted for age, sex, race, BMI, and waist circumference.

  • §

    § P <0.01.

  • P <0.05.

  • P <0.001.